[Idiopathic hypercalciuria. Current physiopathological and therapeutic concepts].
D000138:Acidosis / Q000150:complications; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D001581:Benzothiadiazines; D001847:Bone Diseases / Q000150:complications; D002118:Calcium / Q000652:urine*; D002128:Calcium Metabolism Disorders / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D004164:Diphosphonates / Q000627:therapeutic use; D004232:Diuretics; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D008277:Magnesium Oxide / Q000627:therapeutic use; D008751:Methylene Blue / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D010833:Phytic Acid / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014807:Vitamin D / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D001581:Benzothiadiazines; D004164:Diphosphonates; D004232:Diuretics; D010710:Phosphates; D049993:Sodium Chloride Symporter Inhibitors; D014807:Vitamin D; D008277:Magnesium Oxide; D010833:Phytic Acid; D002118:Calcium; D008751:Methylene Blue
Ipercalciuria idiopatica. Attuali conoscenze fisiopatologiche e terapeutiche.